Position history for CITADEL ADVISORS LLC's holdings in MOONLAKE IMMUNOTHERAPEUTICS
Current Value
$24.7M
Current Shares
1.3M
Total Value Change
-$74.9M
Total Shares Change
-941,967
Increased |
| 1.3M |
+247.5% |
| $24.7M |
| 0.0% |
| $17.69 |
46 |
| 2025-Q4 | Increased | 380,890 | +672.1% | $5M | 0.0% | $13.21 | 43 |
| 2025-Q3 | Decreased | 49,334 | -97.0% | $353,725 | 0.0% | $6.24 | 0 |
| 2025-Q2 | Increased | 1.7M | +13.2% | $79M | 0.0% | $47.52 | 34 |
| 2025-Q1 | Decreased | 1.5M | -32.4% | $57.8M | 0.0% | $39.86 | 0 |
| 2024-Q4 | Decreased | 2.2M | -5.9% | $118.4M | 0.0% | $53.02 | 0 |
| 2024-Q3 | Increased | 2.3M | +2.5% | $117.1M | 0.0% | $49.40 | 31 |
| 2024-Q2 | Decreased | 2.3M | -1.9% | $99.6M | 0.0% | $43.97 | 0 |